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The alms of this study were 1) to evaluate the role
of Wood pressure and associated
neural tonicity in ambient
Ischenis of a group of hypertensive patients with stable angina,
and 2) to Wake the docacy of immediate release
nifedipine
therapy In controllklit the total Ischemic
burden in both office«
measured and ambulatory blood pressure .
fiach,vound
. Low head rate Ischemls, as detected by Holier
ambulatory electrocardiographic monitoring, suggests that re
•
dwmd coronary Ilow is the major factor leading
to ischemla. We
previously fand that 91%
of the ischemic episodes in our
hMrtonslve patients with stable angina were silent.
Ketfwk. We measured plasma norepinephrine content during
Isebessic events ftm blood obtained from automatic
pump with-
drawal with the assistance of a real-time ST
segment depression
moWW
. We then related the norepinephrine content to Ischemic
episodes imsessed by 48-h Holier recording, blood pressure read
.
ing by ambulatory blood pressure monitoring and patients' dia
.
ries
. Measuremenis were taken during the placebo period and
Silent ischemia (ST segment depression on the Holier am-
bulatory electrocardiographic [EGG( monitor while the pa-
tient is without symptoms) is thought to account for 70 to
of the total ischemic burden in patients with or without
subjective clinical evidence of coronary artery disease (1) .
We Previously reported that 91% of the ischcmic episodes in
our hypertensive patients with stable angina were without
symptoms (2). Using simultaneous automatic pump with-
drawal of blood and Holter monitoring in hypertensive
patients in their usual environment, we found that neural
hypertonicity (increased plasma norepinephrine) was asso-
ciated with the ischemic episodes . Furthermore, the cardio-
selective beta-adrenergic receptor antagonist metoprolol ef-
fectively controlled ambulatory blood pressure and heart
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ISCHEMIA
Immediate-release nifedipine therapy in M hypertensive patients
(20 with and 10 without stable angina) .
Results. More twn half of the patients had ischemic
episodes-,
95% of these were silent
. Ischemle episodes peaked In the early
morning, and 55% occurred during routine
sedentary acibides.
There was a 10% to 15% increase In heart rate at the onset of
Ischemla associated with a 30% higher plasma norepinephrine
level. Seventy-five percent of patients had Increased norepineph-
rine after nifedipine therapy . Niledipine therapy controlled mea-
sured blood pressure but not 24-h ambulatory blood pressure.
Ischemle episodes were reduced only in patients whose ambula-
tory blood pressure was controlled.
Conclusions. The results suggest that increased neural tone at
the time of the iselhemic event may play a role in reducing coronary
perfivion leading to silent ischemia . Nifedipine therapy (immediate
release) was effective in control of Ischemia
only when both ambula-
tory
and ollix-measured blood pressure were controlled .
(J Am Coll Cardiol 1"3,22:1438-45)
rate and reduced the frequency and duration of the ischemic
attacks
(2) .
The present study describes the
role of blood
pressure and associated neural tonicity in ambient ischemia
in a group of 20 hypertensive patients with stable angina and
the efficacy of immediate-release nifedipine therapy in con-
trolling the total ischemic burden and both office-measured
and ambulatory blood pressure in 30 hypertensive patients
(20 with and 10 without stable angina) . The results again
suggest a role for increased neural tone in the genesis of
silent ischemia in some hypertensive
patients and describe
the disparate effects of immediate release nifedipine therapy
on neural tone and ischemia. These results reinforce our
previous suggestion that neural factors participate through-
out the day in the silent ischemic events in patients with
hypertension and stable
angina. Further, we found that
ischemic events peak at the time of awakening and their
response to therapy is best when there is control of ambu-
latory as well as office-measured blood pressure .
Methods
Patients. Thirty hypertensive patients with blood pres-
sure in the range of 140 to 160/90 to 105 mm Hg participated
in this study (23 men, 7 women; mean age 58 ± 8 years,
0731109701=00
JACC Vol . 22, No . 5
November 1, 1993 :1438-45
range 42 to 74) . Twenty patients had at least two episodes/
week of angina and 1-mm ST segment horizontal or
downsloping depression during treadmill exercise via the
Bruce protocol . Ten patients had no history of angina, and
two had ECG evidence of previous myocardial infarction .
Patients with unstable angina, congestive heart failure, sig-
nificant valvular or congenital heart disease, uncontrolled
arrhythmia, second- or third-degree atrioventricular block,
previous myocardial infarction within 3 months, associated
major systemic disorders and secondary hypertension were
excluded from the study .
FrAwl The study comprised three phases . Phase I was
a single-blind placebo baseline period . During this period, all
antianginal and antihypertensive medications were discon-
tinued, with the exception of sublingual nitroglycerin and
hydrochlorothiazide (up to 100 ng daily). Potassium chloride
supplementation was added when necessary to maintain
serum potassium >4 .0 mEq/liter . Patients had a complete
medical history, physical examination, routine laboratory
test and ECG . Patients received placebo three times daily for
2 weeks . Supine and standing diastolic blood pressure at two
consecutive visits were required to be in the range 90 to
100 mm Hg at the end of this period. Hydrochlowhiazide
doses were not changed after the baseline period . All pa-
tients were then randomized to a double-blind crossover trial
of placebo and nifedipine (phases II and III) . During phases
11 and III, study medications (placebo or nifedipine), start-
ing at 10 mg three times a day, were initially titrated every
other day until the average of three supine and three stand-
ing blood pressure recordings were 5120/80 mm Hg . After
one patient with no previous history of ischemic heart
disease had a nonfatal myocardial infarction after achiev-
ing "goal diastolic pressure," this average was changed to
:590 mm Hg. Patients were maintained on this dose of
medication for an additional 10 days. Patients not reaching
goal blood pressure after the maximal dose in phase II were
then given the alternative therapy in phase 111 . Patients in
phase III were discontinued from the study after a maximal
dose of 90 mg/day of nifedipine or placebo was reached if
they did not achieve goal blood pressure . Forty-eight-hour
Holter and real-time ECG monitoring (Q-Med or Compas)
were performed simultaneously at the end of each phase
while patients conducted their usual lives, keeping a diary of
their activities, behavior and mood during their 48-h moni-
toring. On I of the 2 days, 24-h ambulatory blood pressure
was recorded every 20 min using Spacelabs model 5200 . On
another day, blood was taken from an antecubital vein for
norepinephrine, epinephrine and normetanephrine measure-
ments after 30 min of supine rest and again after upright
activity for 60 min . Two additional consecutive blood sam-
ples were obtained later in the day through an ambulatory
blood withdrawal pump during the first ST segment depres-
sion episode sensed by the real-time ECG monitor . Echocar-
diograms were also performed at the end of each phase .
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Holter and real-time electrocardiographic monitoring.
The Holler tracing was obtained with an Avionics model 453
recorder . The tapes were analyzed using the compact analog
technique (3,4) . The episodes of ST segment depression
were measured from the Holter recording . ST segment
depression episodes were defined as transient horizontal or
downsloping depression (80 ins after the J point) >1 .0 mm
from baseline, lasting >1 min .
The electrodes for Q-Med or Compas were placed as
close as possible to the Holter electrodes . Downsloping or
horizontal ST segment depression of at least 1 mm lasting
>I min represented the threshold for detection of an event .
A signal (tone) would be emitted when ST segment depres-
sion exceeded the threshold .
Ambulatory blood withdrawall pump . A thromboresistant
butterfly needle with a nonthrombogenic tube was inserted
into a forearm vein. Supine and standing blood samples for
plasma norepinephrine, epinephrine and normetanephrine
were drawn, and the catheter was filled with heparinized
saline solution and attached to the ambulatory blood with-
drawal pump (Cormed ML6) . The pump was set to withdraw
blood continuously at a rate of I ml/min (5), as activated by
the patient in response to the first tone elicited by C"Med or
Compas. Consecutive blood samples were withdrawn, the
first during the initial 10 min of ischemia and the second
during the next 10 min . Plasma norepinephrine and epineph-
rine (6) and normetanephrine (7) were measured through
high performance liquid chomatographic and enzymatic
methods, respectively . The Holter and Q-Med/Compas ECG
tracings were inspected to confirm the presence of ST
segment depression during the alarm . The tracings were
classified as "episode of ST depression" when both Holter
monitor and Q-Med/Compas tracings revealed ischemic S1
segment changes . Blood samples collected because of im-
proper signals (i.e ., broken or loose leads) and without any
evidence of Holter or Q-Med/Compas data were identified as
nondepression (false alarms) .
Left ventricular mass. Left ventricular mass was mea-
sured by two-dimensional and M mode echocardiography
using an ATL Ultramark IV (8). Measurements were made
in the left lateral decubitus position on three complexes.
Leading edge techniques, as recommended by the American
Society of Echocardiography, were used to measure septal
and posterior wall thickness and left ventricular dimension .
Left ventricular mass was calculated with the formula pro-
posed by Devereux (9) :
0.8 x [1 .04 x (LVSTd + 1,1111)d + PWTd)3
- (LV[Dd)3] + 0 .6 (g),
where LVSTd and LVIDd =
; left ventricular septal wall
thickness (diastole) and left ventricular internal dimension
(diastole), respectively, and PWTd = posterior wall thick-
ness (diastole) .
Statistical analysis. Data presented are mean value ± SE
.
Student t tests were used to compare variables, such as ST
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Table 1 . Effect of Nifedipine Therapy on the Frequency and Duration of ST Segment Depression
and Office-Measured and Mean 24-h Ambulatory Blood Pressure
;p < 0.01 compared with placebo . Values presented are mean value ± SE or number of patients .
segment depression, blood pressure and left ventricular
mass index, between placebo and nifedipine treatment .
Analysis of variance followed by multiple comparisons was
used to compare mean heart rate for 24 h with heart rate
during ST segment depression. A p value < 0 .05 was
considered significant .
Results
The average dose of nifedipine given to this group of
hypertensive patients was 50.3 mg/day. Eight patients (27%0)
received 20 mg/day ; eight (27%) received 30 mg/day ; five
(16%) received 60 mg/day ; and nine (30%) received
90 mg/day .
Effect of nifedipine therapy on blood pressure and ST
t depression in 30 hypertensive patients (20 with and 10
without ) . Overall, nifedipine therapy did not change
the frequency and duration of ST segment depression (Table
1). Although both supine and standing office-measured blood
pressure were controlled by nifedipine, the mean 24-h am-
bulatory blood pressure was not changed by nifedipine
therapy (Table 1) .
Table 2. Comparison of the Frequency and Duration of ST Segment Depression, Office-Measured and Mean 24-h Ambulatory Blood
Pressure in 20 Hypertensive Patients With and 10 Without Angina
Values presented
are mean values ± SD or number
. pis = patients.
Placebo
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The frequency and duration of ST segment depression,
both supine & d standing blood pressure measured at the
office and the mean 24-h ambulatory blood pressure did
not differ in 20 hypertensive patients with and 10 without
angina who received either placebo or nifedipine therapy
(Table 2) .
Effect of nifedipine therapy on ST segment depression in
patients who had ST segment depression . Seventeen of 30
patients (10 with angina, 7 asymptomatic) had a total of 174
ST segment depression events on at least I of the 6 days of
ambulatory ECG monitoring. Eight events were with pain,
95% without pain. Thirteen patients had ST segment depres-
sion during the placebo period . After nifedipine therapy, 4 of
these 13 patients had no ST segment depression, and 4 had
reduced and 4 increased duration of ST segment depression,
respectively (one patient had no record because of equip-
ment failure) . Four patients had ST segment depression only
during nifedipine therapy, not during the placebo period . Of
these 17 patients, 3 had significant Q waves, suggesting a
previous myocardial infarction ; 2 had nonspecific 0.5-mm ST
segment depression in R wave-dominant leads ; 2 had no
specific T wave flattening ; I had an inverted T wave on the
Nifedipine
Patients
(no .)
Placebo
Nifedipine
ST segment depression
Frequency (episodes/24 h)
26 1 .68 ± 0 .48 0.88 ± 0 .30
Duration (min/24 h)
26 25.24 ± 9 .49 22 .78 ± 13.63
Office-measured blood pressure (mm Hg)
Supine 30 147 ± 3191 ± 2 134 ± 2186 ± 1*
Standing
30 148±3194±2 136±3/86±I
Mean 24-h ambulatory blood pressure (mm Hg) 29 143±3189±2 139±3187± I
With Angina
Without Angina With Angina Without Angina
Si c
	
tat depression (no
. of pts) 16
10 16
I0
Frequency (episode 44 h)
1.39 ± 0.49
2 .13 ± 1 .04 0.77 ± 0 .22 1 .07 ± 0 .73
Duration (min/24 h)
15 .63 ± 6 .02 40.61 ± 25 .00
11 .73 ± 5 .01 40 .47 ± 36 .23
sured blood pressure (no
. of pts)
20 10
20 10
Supine (mm Hg)
Systolic
147±4 146±3
135 ± 3
132 -
__*4
tol :
90±2 92±2 86±1 85±2
Standing (mm Hg)
Systolic
150 ± 4 144±4
136±3 135±5
Diastolic
93±2
95±2
86±2 87±3
Man 24-hour ambulatory blood pressure
19
10 19
10
(no. of pts)
Systolic (mat Hg)
141 ± 3
147 ± 3
118 ± 2 142 ± 3
Diastolic (mm Hg)
88 2
94±3
86±±2 89±2
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Figure 1 . Distribution of the events of ST segment depression
during the 24-h period .
baseline ECG ; and 9 had a normal baseline ECG . The patient
who had no record during nifedipine therapy was excluded
from the analysis of ST segment depression events . The
average number of ST segment depression episodes in the
remaining 16 patients was 2 .7 ± 0.8124 h, with an average
duration of 35 .9 ± 16.0 min/24 h. Nifedipine therapy did not
reduce the frequency (1 .4 ± 0 .4/24 h) or duration (37 .0 ±
22 .5 min/24 h) of ST segment depression in these 16 patients
(see Fig. 4) .
The number of ischemic events was distributed through-
out the 24-h day ; however, most events occurred during the
awake period, and there was a peak at 8 :00 to 11 :00 AM, with
a smaller. lesser peak occurring late in the afternoon (Fig . 1) .
The rate of silent ischemic events was lowest in the early
morning hours. Generally, the episodes were <5 to 30 min in
duration (Fig . 2) . Of all the events recorded in the patients'
diaries, about 60% weree associated with either routine
activities or sleep . Fewer than one-third of the ischemic
episodes were associated with physical activity or driving an
automobile (Fig . 3) .
Among 16 patients who had ST segment depression,
nifedipine therapy controlled the mean 24-h ambulatory
blood pressure in 6 (i .e., blood pressure was reduced to
< 140/90 mm Hg or by > 10%). The frequency and duration of
ST segment depression were reduced in these six patients
(3 .7 ± 1 .1/24 h vs . 0.7 ± 0.3/24 h, p < 0.05, and 42.1 ±
16.8 vs . 7.3 ± 2.9 min/24 h, p < 0. 1, respectively) but were
unchanged in the othe patients without control of 24-h
ambulatory blood pressure by nifedipine therapy (2 .2 ±
1.0/24 h vs . 1 .9 ± 2.7/24 h and 40.4 ± 24.3 vs. 54.9 ±
34.6 minJ24 h, respectively) (Fig . 4). The frequency and
duration of ST segment depression during the placebo period
tended to be higher in the six patients with, than in the 10
patients without, control of ambulatory blood pressure (p
NS) .
401
20
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Figure 2 . Percent distribution of the duration of ST segment depres-
sion .
Blood pressure and heart rate during ST segment depres.
sion. Twenty-four-hour blood pressure was recorded dur-
ing episodes of ST segment depression on the ambulatory
blood pressure monitor in 14 of the 16 patients who had ST
depression during the baseline, placebo or nifedipine period .
The average blood pressure during ST segment depression
was higher than the mean 24-h blood pressure (157 ± 4/94 ±
3 vs. 145 ± 2/90 ± 1 mm Hg, p < 0.05). The heart rate at
the onset of each episode of ST segment depression and
the maximal heart rate during each episode recorded
by the Holter monitor exceeded the mean 24-h heart rate
during the baseline, placebo and nifedipine periods
(Fig. 5) .
Plasma norepinephrine. Seventy-five percent and 68% of
patients had a higher supine and upright plasma norepineph-
Figure 3 . Percent distribution of activities during ST segment de-
pression .
ROUTINE
37.4%
NO DIARY
184%
SLEEPING
17.8%
PHYSICAL
ACTIVITIES
14
.9%
I
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Film 4. Effect of nifedipine therapy on the frequency and duration
of ST segment depression in patients with (upper panel) and without
{fewer pond) controlled 24-h ambulatory blood pressure . Open and
hatched bars represent before and during nifedipine therapy, respec-
tively . *p < 0.05 . +p < O.L
rine concentration, respectively, during nifedipine therapy
compared with the placebo period . Elevations of both supine
and upright plasma norepinephrine levels were significant
(309 22 vs. 239 ± 24 ng/liter, p < 0 .01, and 638 ± 44 vs .
540 56 ng/liter, p < 0,05, respectively) .
Blood samples were obtained during the first Holler and
Q-Med documented episodes of ST segment depression in
eight, nine and six patients during the baseline, placebo and
nifedipine periods, respectively . Two consecutive blood
samples during the same episodes of ST segment depression
were obtained in three, four and three patients during the
baseline, placebo and nifedipine period, respectively . There-
fore, plasma norepinephrint, epinephrine and normetaneph-
rine were measured in a total of 33 blood samples with
documented ST segment depression . Of the 33 samples. I I
were obtained when patients were reclining and resting
(subdued behavior): 6, 3 and 2 during the baseline, placebo
and nifedipine period, respectively . Fourteen samples were
obtained during physical activity : four, seven and three
during the baseline, placebo and nifedipine period, respec-
tively. Eight samples were obtained during unknown activ-
120
100
400
300
200
100
0
BASELINE
(12)
6
NE
PLACEBO
(12)
E
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Figure S. Heart rate during ST segment depression. Open bars
represent mean 24-h heart rate . [latched bars represent the heart
rate at onset of episodes . Solid bars represent maximal heart rate
during episodes . *p < 0.05 versus mean heart rate . **p < 0 .01
comparison of mean, onset and maximal heart rate .
ity. Plasma norepinephrine during ST segment depression
obtained during subdued behavior was increased by 51%
compared with rest supine values (360 ± 58 vs . 238 t
21 nglliter, p < 0.05). Plasma norepinephrine during ST
segment depression obtained during physical activity was
42% higher than the upright ambulatory value (576 ± 100 vs .
405 ± 52 nglliter, p < 0 .05). Plasma epinephrine and normet-
anephrine levels during ST segment depression were not
different from their respective rest or upright values (Fig . 6
and 7) .
However, 25 blood samples were obtained after a false
Q-Med alarm without Holter or Q-Med documentation of ST
segment depression . Ten of these ? .vrrples were obtained
during subdued behavior, seven during physical activity and
eight during unknown activity . Plasma norepinephrine levels
Figure 6. Comparison of plasma catecholamines at the time of ST
segment depression during subdued behavior and baseline values .
Open and hatched bars represent supine and ST segment depression,
respectively . E = epinephrine; NE = norepinephrine ; NMN
normetanephrine. *p < 0.05.
500 r
NMN
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Figure 7. Comparison of plasma catechoku-nims at the time of ST
segment depression during physical activity and baseline upright
values. Open and hatched has represent upright values and values
at the time of ST segment depression . respectively . Abbreviations
as in Figure 6 . V < OAS .
obtained during subdued or active behavior was not different
from rest or upright values (Table 3) .
Left ventricular mass and ventricular ectopic beats .
Twenty of 29 patients had left ventricular hypertrophy . The
prevalence of left ventricular hypertrophy was not different
in patients with or without ST segment depression . Eleven
(69%) of the 16 patients with and 9 (69%) of the 13 patients
without ST segment depression on Halter monitoring had
left ventricular hypertrophy . Left ventricular mass index
was not different in patients with and without ST depression
(138 ± 3 vs. 130 ± 6 g/m', p = NS) . Compared with values
in the placebo period, nifedipine therapy did not change
septal and posterior wall thickness, left ventricular mass
index and ejection fraction (1 .3 ± 0.04 vs . 1 .3 ± 0.04 cm,
1 .2 0.04 vs . 1 .2 ± 0.04 cm, 135 ± 4 vs . 135 ± 4 g/m 2 and
62 2% vs. 66 ± 2%, respectively) . The effect of nifedipine
therapy on ST segment depression was not related to left
ventricular hypertrophy. Of the 7 of 16 patients who had
decreased duration of ST segment depression during nifedi-
pine therapy, 5 (71%) had left ventricula7 hypertrophy . The
other nine patients had no change in ST segment depression
during nifedipine therapy and six of these (67%) had left
ventricular hypertrophy .
Twenty-five of 30 patients had ventricular ectopic beats
on at least I of the 6 days of ambulatory Holter monitoring .
Table 3. Plasma Catecholamines at the Time of False Alarms and at Baseline
700
i 500
100
NU
I SON
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Nifedipine therapy did
hot change the frequency of ventric-
ular ectopic beats from values in the placebo period (668
398/24 h vs
. 579 ± 365/24 h with placebo) .
DiSCUSSiomn
Silent Ischemia and the Role of the
S),inpothetic Nervous System in
Hypertensive Patients
Pathogenic mechanism . Silent myocardial ischemia is a
frequent event in the daily life of normotensive patients with
stable angina (1) . We found that in patients with hyperten-
sion and stable angina, >90% of ischemic episodes were
without symptoms (2) . The findings of a lower heart rate-
blood pressure product in normotensive patients at the time
of their Filent ischemic episodes compared with that at the
time of onset of ischernia on treadmill testing suggests that
impaired coronary blood flow is a prominent factor in the
ischernia of ambulatory normotensive patients (10) .
We found similar hemodynamic changes in our hyperten-
sive patients, suggesting a role for altered coronary flow
reserve at the time of heightened neural tone . Norepineph-
rine levels were 50% higher at the time of ischemia compared
with nonischemic intervals, an increment similar to our
previous finding (2) . The coronary vasculature is rich in
sympathetic innervation (11), yet earlier studies of neural
tone in ischemia found either no relation or suggested that
altered noradrenergic status was secondary to the ischernia
(12) . Norepinephrine and epinephrine increased in some
patients with vasospastic ischemia before onset (13). A
neural role is implied in those patients with ischemia who
responded to alpha-adrenergic receptor blockade (14,15) .
Recent evidence suggests that normal stress may evoke
sympathetic stimulation that can interact with abnormal
endothelial function to yield coronary vasoconstriction in
patients with minimal coronary atherosclerosis (16) .
We view the increase in peripheral plasma norepineph-
rine as a marker of generalized sympathoadrenal release, the
latter leading to both enhanced coronary vasoconstriction
and myocardiall oxygen demand . Sympathoadrena! re-
sponses to various physical (17), mental (17) and emotional
stress (18) or fluctuations in neural tone related to circadian
patterns (19) are usually accompanied by elevations in
peripheral plasma norepinephrine as well as the hemody-
namic patterns of the "fight or flight response ." Although it
is not the usual sequence of events, there are reports of
Values presented are mean value ± SD or number . E = epinephrine -, NE = norepinephrine
; NMN = normetanephrine : Pt = patient .
Behavior
Pt
No.
False Alarm
Baseline, Supine or tJlnight
NE E
NMN
NE E NMN
Subdued 10 336 ± 62 71 ± 13
219 ± 38 341 ± 48
36±3 10 ± 24
Physical activity 7 544 ± 31
27±8 245 ± 31 563 ± 24 22±4
241 ± 20
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increased blood pressure and pulse rate after ischemia in
some hypertensive patients (2t)), related perhaps to
checnoreceptors sensing coronary ischemia (21) and to isch-
emic stress (22,23) . Plasma norepinephrine was normal when
the alarm was "false" and not associated with ischemia, as
we also found previously (2) . Several of the ischemic
episodes were associated with emotional stress and did not
seem to be related to physical activity .
impaired of nifedipine .
Nifedipine therapy in-
creased plasma norepinephrine compared with the value
obtained with placebo during both ischemic and nonischemic
periods, comfirming findings of Corea et al . (24) . There were
no significant changes in plasma norepinephrine in a similar
trial with metoprolol (2) . Nifedipine did not reduce ischemia
overall in patients in this study despite control of office-
measured blood pressure . However, nifedipine reduced isch-
emia in a smaller subgroup with control of office-measured
and ambulatory blood pressures . Nifedipine therapy pro .
duced repolarization abnormalities (T wave inversion) in
association with rapid blood pressure reduction, but ST
segment depression was not observed (25) .
Thirty percent of patients had no ischemia after nifedipine
therapy. Metoprolol, more effective in our earlier study (2),
was thought to reduce ischemic burden by reducing myocar-
dial oxygen consumption (26) and, possibly, improving cor-
onary flow reserve during stress by blocking epinephrine-
mediated noradrenergic vasoconstriction of coronary
arterioles (27) . Nifedipine therapy was effective when am-
bulatory blood pressure was lowered, perhaps implying an
important reduction in myocardial oxygen consumption .
However, its effectiveness as a concomitant coronary vaso-
dilator may have been blunted by the reflex increase in
noradrenergic tone. In a recent comparative trial in normo-
tensive patients with "mixed" angina, both at rest and
during effort, metoprolol was as effective as we had found it
to be in hypertensive patients, whereas nifedipine was
relatively ineffective (28) .
I ion with arterial endothelial function . Regularly
occurring neural stimulation during routine life events, not
necessarily excessive noradrenergic tone, may contribute
greatly to ischemia. Endothelium-mediated coronary vaso-
dilation appears to increase coronary flow in patients with
normal coronary vessels (16) . The presence of atherosclero-
sis or the risk factors of cholesterol and smoking convert this
response to one of coronary vasoconstriction (16) . Further,
intact endothelium buffers norepinephrine release during
cold and other stresses at presynaptic sites (29) . However,
alpha-adrcr ergic receptor-mediated arteriolar tone is
thought to prevent epicardial steal of coronary flow by
shifting blood flow to ischemic subendocardial areas (11,30) .
The rapid decrease in blood pressure after nifedipine
therapy may induce counterregulatory sympathetic reflexes
that override the direct smooth muscle relaxation . Thus, the
later increase
di blood pressure may result in increased
myocardial oxygen demand at a time of neurally mediated
reduced coronary perfusion
. These data and those from
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hypertensive patients in our previous studies (2,31) implicate
a role for sympathetic neural dysfunction in silent ischemic
episodes in some hypertensive patients with stable angina .
We view the sympathoadrenal responses as possibly
appropriate for the challenge, but the response to the nor-
adrenergic stimuli may have been accentuated . There are
several lines of evidence that connect sympathetic stimula-
tion and endothelial dysfunction to abnormal coronary va-
somotion . Further, the presence of even minute quantities of
coronary vascular atheromas convert a sympathetic stimulus
from one causing coronary vasodilation to one causing
coronary vasoconstriction (16) . Thus, treatment strategies
that blunt neural tone as well ,.s augment coronary vasodi-
lation appear to be more effective for ischemia contl . ' . The
addition of propranolol to nifedipine therapy provid i er
control of ischemia in patients with unstable angina than did
nifedipine monotherapy (32). Extended release nifedipine
provided more ischemia control than did immediate release
nifedipine (33) . Thus, there appears to be evidence for a
strong and important influence of symptW~=3,aA
=
; . ! ,a-
tion in hypertensive heart disease through trophic effects on
left ventricular mass and perhaps through detrimental effects
on increasing myocardial oxygen demand and through re-
ducing coronary flow reserve .
We gratefully acknowledge the assistance of Bramah Singh, MD in interpret-
ing the Holier tapes .
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